In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

Bibliographic Details
Main Authors:	Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Jon Thor Asmussen, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Schmidt Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Fredrik Schjesvold, Nordic Myeloma Study Group
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-01046-2

Internet